Abdulmajeed Aydh

689 total citations
38 papers, 419 citations indexed

About

Abdulmajeed Aydh is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Abdulmajeed Aydh has authored 38 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 21 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Abdulmajeed Aydh's work include Bladder and Urothelial Cancer Treatments (17 papers), Prostate Cancer Treatment and Research (13 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Abdulmajeed Aydh is often cited by papers focused on Bladder and Urothelial Cancer Treatments (17 papers), Prostate Cancer Treatment and Research (13 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Abdulmajeed Aydh collaborates with scholars based in Austria, Saudi Arabia and Japan. Abdulmajeed Aydh's co-authors include Reza Sari Motlagh, Shahrokh F. Shariat, Keiichiro Mori, Benjamin Pradère, Fahad Quhal, Ekaterina Laukhtina, Hadi Mostafaei, Pierre I. Karakiewicz, Paweł Rajwa and Frederik König and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and European Urology.

In The Last Decade

Abdulmajeed Aydh

38 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abdulmajeed Aydh Austria	13	212	182	126	70	47	38	419
Maximilian Pallauf Austria	12	245 1.2×	149 0.8×	61 0.5×	72 1.0×	38 0.8×	57	447
Einar Brekkan Sweden	13	171 0.8×	122 0.7×	76 0.6×	79 1.1×	45 1.0×	20	376
C. Lebâcle France	12	185 0.9×	227 1.2×	74 0.6×	63 0.9×	82 1.7×	47	408
Cheng‐Kuang Yang Taiwan	13	164 0.8×	116 0.6×	41 0.3×	62 0.9×	46 1.0×	42	346
Toru Nishiyama Japan	12	238 1.1×	160 0.9×	83 0.7×	27 0.4×	27 0.6×	42	468
Giuseppe Di Fino Italy	13	159 0.8×	148 0.8×	42 0.3×	80 1.1×	69 1.5×	26	374
Andrea Panunzio Italy	10	212 1.0×	120 0.7×	31 0.2×	72 1.0×	64 1.4×	80	346
Jason W. Anast United States	9	306 1.4×	113 0.6×	132 1.0×	46 0.7×	59 1.3×	12	495
Jay S. Belani United States	10	245 1.2×	90 0.5×	110 0.9×	85 1.2×	97 2.1×	13	457
Shicong Lai China	11	161 0.8×	89 0.5×	51 0.4×	71 1.0×	53 1.1×	41	285

Countries citing papers authored by Abdulmajeed Aydh

Since Specialization

Citations

This map shows the geographic impact of Abdulmajeed Aydh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdulmajeed Aydh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdulmajeed Aydh more than expected).

Fields of papers citing papers by Abdulmajeed Aydh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdulmajeed Aydh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdulmajeed Aydh. The network helps show where Abdulmajeed Aydh may publish in the future.

Co-authorship network of co-authors of Abdulmajeed Aydh

This figure shows the co-authorship network connecting the top 25 collaborators of Abdulmajeed Aydh. A scholar is included among the top collaborators of Abdulmajeed Aydh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdulmajeed Aydh. Abdulmajeed Aydh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laukhtina, Ekaterina, Fahad Quhal, Keiichiro Mori, et al.. (2022). Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy. European Urology Oncology. 5(1). 120–124. 9 indexed citations

Motlagh, Reza Sari, Takafumi Yanagisawa, Tatsushi Kawada, et al.. (2022). Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis. Prostate Cancer and Prostatic Diseases. 25(2). 187–198. 12 indexed citations

König, Frederik, Benjamin Pradère, Nico C. Grossmann, et al.. (2022). Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review. Translational Cancer Research. 11(4). 908–917. 2 indexed citations

Motlagh, Reza Sari, Victor M. Schuettfort, Keiichiro Mori, et al.. (2022). Prognostic impact of insulin‐like growth factor‐I and its binding proteins, insulin‐like growth factor‐I binding protein‐2 and ‐3, on adverse histopathological features and survival outcomes after radical cystectomy. International Journal of Urology. 29(7). 676–683. 2 indexed citations

Parizi, Mehdi Kardoust, Vitaly Margulis, Yair Lotan, Abdulmajeed Aydh, & Shahrokh F. Shariat. (2022). A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer. Clinical Genitourinary Cancer. 21(3). 317–323. 1 indexed citations

Motlagh, Reza Sari, Paweł Rajwa, Keiichiro Mori, et al.. (2021). Comparison of Clinicopathologic and Oncological Outcomes Between Transurethral En Bloc Resection and Conventional Transurethral Resection of Bladder Tumor: A Systematic Review, Meta-Analysis, and Network Meta-Analysis with Focus on Different Energy Sources. Journal of Endourology. 36(4). 535–547. 19 indexed citations

Aydh, Abdulmajeed, Keiichiro Mori, David D‘Andrea, et al.. (2021). Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy. International Journal of Clinical Oncology. 26(9). 1729–1735. 5 indexed citations

Aydh, Abdulmajeed, Shahrokh F. Shariat, Reza Sari Motlagh, et al.. (2021). Evaluation of the Guidelines for Penile Cancer Treatment: Overview and Assessment. SHILAP Revista de lepidopterología. 2(3). 171–186. 2 indexed citations

Mostafaei, Hadi, Keiichiro Mori, Fahad Quhal, et al.. (2021). The placebo and nocebo effects in functional urology. Nature Reviews Urology. 19(3). 171–189. 10 indexed citations

10.

Aydh, Abdulmajeed, Reza Sari Motlagh, Keiichiro Mori, et al.. (2021). Association of statins use and mortality outcomes in prostate cancer patients who received androgen deprivation therapy: a systematic review and meta-analysis. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 74(4). 484–490. 5 indexed citations

11.

Laukhtina, Ekaterina, Benjamin Pradère, Keiichiro Mori, et al.. (2021). Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review. Urologic Oncology Seminars and Original Investigations. 39(8). 471–479. 10 indexed citations

12.

Yanagisawa, Takafumi, Keiichiro Mori, Satoshi Katayama, et al.. (2021). Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis. International Journal of Clinical Oncology. 27(1). 59–71. 22 indexed citations

13.

Grossmann, Nico C., Victor M. Schuettfort, Benjamin Pradère, et al.. (2021). Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy. Urologic Oncology Seminars and Original Investigations. 40(3). 106.e11–106.e19. 17 indexed citations

14.

Laukhtina, Ekaterina, Reza Sari Motlagh, Keiichiro Mori, et al.. (2021). Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Critical Reviews in Oncology/Hematology. 169. 103570–103570. 9 indexed citations

15.

Luzzago, Stefano, Mattia Luca Piccinelli, Giulia Marvaso, et al.. (2021). Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies. World Journal of Urology. 40(2). 443–451. 3 indexed citations

16.

Quhal, Fahad, Benjamin Pradère, Reza Sari Motlagh, et al.. (2021). Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer. Minerva Urology and Nephrology. 73(5). 5 indexed citations

17.

Motlagh, Reza Sari, Mohammad Abufaraj, Keiichiro Mori, et al.. (2021). The Efficacy and Safety of Relugolix Compared with Degarelix in Advanced Prostate Cancer Patients: A Network Meta-analysis of Randomized Trials. European Urology Oncology. 5(2). 138–145. 10 indexed citations

18.

Motlagh, Reza Sari, Keiichiro Mori, Noriyoshi Miura, et al.. (2020). The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta‐analysis. British Journal of Urology. 127(2). 143–152. 6 indexed citations

19.

Laukhtina, Ekaterina, Hadi Mostafaei, David D‘Andrea, et al.. (2020). Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC). World Journal of Urology. 39(6). 1961–1968. 12 indexed citations

20.

Miura, Noriyoshi, Keiichiro Mori, Hadi Mostafaei, et al.. (2020). Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis. International Journal of Clinical Oncology. 25(11). 1881–1891. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact